Medical therapy for induction and maintenance of remission in pouchitis: A systematic review

Inflammatory Bowel Diseases

Volumn 5, Issue 1, 1999, Pages 33-39

  Sandborn, William J ^a   McLeod, Robin ^b   Jewell, Derek P ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Pouchitis; Ulcerative colitis

Indexed keywords

ANTIINFECTIVE AGENT; ENEMA; GASTROINTESTINAL AGENT;

ADULT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; ILEITIS; LONG TERM CARE; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; REVIEW; RISK; SUPPOSITORY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CONFIDENCE INTERVALS; ENEMA; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; LONG-TERM CARE; MALE; ODDS RATIO; POUCHITIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; REMISSION INDUCTION; SUPPOSITORIES; TREATMENT OUTCOME;

EID: 0033073826     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199902000-00005     Document Type: Review

References (34)

1. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107:1856-60.
2. Di Febo G, Miglioli M, Lauri A, Biasco G, Paganelli GM, Poggioli G, Gozzetti G, Barbara L. Endoscopic assessment of acute inflammation of the reservoir after restorative ileoanal anastomosis. Gastrointest Endosc 1990;36:6-9.
3. Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986;1:167-74.
4. Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40:601-7.
5. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis following ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994;69:409-15.
6. Sandborn WJ. Pouchitis: definition, risk factors, frequency, natural history, classification, and public health perspectives. In: Trends In Inflammatory Bowel Disease 1996. McLeod RS, Martin F, Sutherland LR, Wallace JL, Williams CN, eds. Lancaster, England: Kluwer Academic Publishers 1997;51-63.
7. McLeod RS, Cohen Z, Taylor DW, Cullen JB. Single-patient randomised clinical trial. Use in determining optimum treatment for patients with inflammation of Kock continent ileostomy reservoir. Lancet 1986;1:726-8.
8. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994;39:1193-6.
9. Gionchetti P, Rizzello F, Venturi A, Matteuzzi D, Rossi M, Peruzzo S, Poggioli G, Bazzocchi G, Campieri M. Maintenance treatment of chronic pouchitis: a randomised placebo-controlled, double-blind trial with a new probiotic preparation. Gastroenterology 1998;114:A985.
10. Tremaine WJ, Sandborn WJ, Wolff BG, Carpenter HA, Zinsmeister AR, Metzger PP. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997;11:1041-6.
11. Wischmeyer P, Pemberton JH, Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993;68:978-81.
12. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, Gores GJ, Phillips SF. Fecal bile acids, short chain fatty acids, and bateria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995;40:1474-83.
13. Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989;4:205-29.
14. Natori H, Utsunomiya J, Yamamaura T, Benno Y, Uchida K. Fecal and stomal bile acid composition after ileostomy or ileoanal anastomosis in patients with chronic ulcerative colitis and adenomatous coli. Gastroenterology 1992;102:1278-88.
15. Zuccaro G, Fazio VW, Church JW, Lavery IC, Ruderman WB, Farmer RG. Pouch ileitis. Dig Dis Sci 1989;34:1505-10.
16. Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, Van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211:622-9.
17. Svaninger G, Nordgren S, Oresland T, Hulten L. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993;28:695-700.
18. Kelly DG, Phillips SF, Kelly KA, Weinstein WM, Gilchrist MJR. Dysfunction of the continent ileostomy: clinical features and bacteriology. Gut 1983;24:193-201.
19. Boerr LA, Sambuelli AM, Sugai E, Graziano A, Valero J, Kogan Z, Bai J. Faecal alpha-1-antitrypsin concentration in the diagnosis and management of patients with pouchitis. Eur J Gastroenterol Hepatol 1995;7:129-33.
20. Boerr LA, Sambuelli AM, Filinger E, Peredo A, Graziano A, Valero J, Kogan Z, Bai JC. Increased mucosal levels of leukotriene B4 in pouchitis: evidence for a persistent inflammatory state. Eur J Gastroenterol Hepatol 1996;8:57-61.
21. Kmiot WA, Hesslewood SR, Smith N, Thompson H, Harding LK, Keighley MRB. Evaluation of the inflammatory infiltrate in pouchitis with 111-In-labeled granulocytes. Gastroenterology 1993; 104:981-8.
22. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of incidence, timing, and treatment of pouchitis in 104 consecutative patients after restorative proctocolectomy. Arch Surg 1996;131:497-502.
23. Scott AD, Phillips RKS. Ileitis and pouchitis after colectomy for ulcerative colitis. Br J Surg 1989;76:668-9.
24. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2-7.
25. Kruis W, Scutz P, Stolte M, Fixa OB, Fric P, Judmaier W. Double-blind comparison between mesalamine (Salofalk) and a preparation of viable E. coli Nissle 1917 (Mutaflor) for maintenance therapy of ulcerative colitis. Gastroenterology 1995;108:A853.
26. Nasmyth DG, Godwin PGR, Dixon MR, Williams NS, Johnston D. Ileal ecology after pouch-anal anastomosis or ileostomy. Gastroenterology 1989;96:817-24.
27. Clausen MR, Tvede M, Mortensen PB. Short-chain fatty acids in pouch contents with and without pouchitis after ileal pouch-anal anastomosis. Gastroenterology 1992;103:1144-53.
28. De Silva HJ, Ireland A, Kettlewell M, Mortensen N, Jewell DP. Short-chain fatty acid irrigation in severe pouchitis. N Engl J Med 1989;321:416-17.
29. Tremaine WJ, Sandborn WJ, Phillips SF, Pemberton JH, Carpenter HA. Short-chain fatty acid (SCFA) enema therapy for treatment-resistant pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC). Gastroenterology 1994;106:A784.
30. Den Hoed PT, van Goch JJ, Veen HF, Ouwendijk RJT. Severe pouchitis successfully treated with short-chain fatty acids. Canadian J Surg 1996;39:168-9.
31. Pullan RD, Ganesh S, Mani V, Morris J, Evans BK, Williams GT, Rhodes J. Comparison of bismuth citrate and 5-aminosalicylate acid enemas in distal ulcerative colitis: a controlled trial. Gut 1993; 34:676-9.
32. Gionchetti P, Rizzello F, Venturi A, et al. Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis. Aliment Pharmacol Ther 1997;11:673-8.
33. Parihar GA, Malhotra P, Singh GB, Ludtke R, Safayhi H, Ammon HPT. Effects of boswella serrata gum resin in patients with ulcer-ative colitis. Eur J Med Res 1997;2:37-43.
34. Tremaine WJ, Sandborn WJ, Kenan ML. Bismuth subsalicylate tablets for chronic antibiotic-resistant pouchitis. Gastroenterology 1998;114:A1101.